FDA approves nation's 1st CRISPR gene therapy to treat sickle cell disease: Experts react
The FDA approved the nation's first medicine based on CRISPR gene-editing technology to treat patients with sickle cell disease, a major scientific advancement
Stay updated with breaking news from Comer Children. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA approved the nation's first medicine based on CRISPR gene-editing technology to treat patients with sickle cell disease, a major scientific advancement
Vertex and CRISPR Therapeutics have announced FDA approval for CASGEVY in treating sickle cell disease. Utilizing cutting edge CRISPR/Cas9 gene editing technology, a patient’s own genes are extracted, edited, and then reinserted to eliminate sickle cell in this new therapy.
– First-ever approval of a CRISPR-based gene-editing therapy in the U.S. –– Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment –– Multiple authorized treatment centers activated –BOSTON & ZUG, Switzerland--(BUSINESS WIRE)--Vertex Ph...
NASCAR and Blue Cross and Blue Shield of Illinois are bringing holiday cheer to Comer Children's Hospital.
The race takes place on July 6 and 7, so start making your plans! -Dave and Kim